PT - JOURNAL ARTICLE AU - Valéry Ridde AU - Mouhamadou Faly Ba AU - Ibrahima Gaye AU - Amadou Ibra Diallo AU - Emmanuel Bonnet AU - Adama Faye TI - Participating in vaccine research for COVID-19 in Senegal: trust and information AID - 10.1101/2021.04.07.21255079 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.07.21255079 4099 - http://medrxiv.org/content/early/2021/04/13/2021.04.07.21255079.short 4100 - http://medrxiv.org/content/early/2021/04/13/2021.04.07.21255079.full AB - This research aims to understand the level and determinants of people’s willingness to participate in a vaccine trial for COVID-19 in Senegal. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years of age. Only 44.3% of the participants wanted to participate in a vaccine trial for COVID-19, with females intending to participate more than males. Participants who intended to be vaccinated against COVID-19 (OR = 6.48, 95% CI [4.12-10.4]) and who thought that being infected with the coronavirus would have a significant impact on their health (OR = 2.34, 95% CI [1.57, 3.51]) were more likely to agree to take part in the COVID-19 vaccine research. Confidence in the vaccine, health personnel, and government in the fight against the pandemic are key factors in intending to participate in vaccine research in Senegal.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was conducted as part of the ARIACOV programme (Appui a la Riposte Africaine a l'epidemie de Covid-19), which receives funding from the French Development Agency through the "COVID-19 - Sante en commun" initiative.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the National Ethics Committee for Health Research in Senegal (SEN/20/23). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request to the authors.